Antibiotic (discs µg) Sensitive (95% CIConfidence Interval) Intermediate
(95% CI)
Total (%)
Amikacin (30) 55 (64.37-84.28) 15 (11.11-29.43) 70 (94.59) 4 (0.25-10.56)
Amoxicillin(10) 5 (1.04-12.47) 6 (1.89-14.33) 11 (14.86) 63 (77.03-93.24)
Azithromycin(15) 53 (61.35-81.89) 16 (18.11-38.65) 69 (93.24) 5 (1.04-12.47)
Cefixime(5) 46 (51.11-73.21) 19 (15.72-35.63) 65 (87.83) 9 (4.72-19.61)
Ceftriaxone(30) 44 (48.27-70.65) 22 (19.32-40.14) 66 (89.18) 8 (3.74-17.88)
Cephalexin(30) 35 (35.91-58.67) 25 (23.01-44.56) 60 (81.08) 14 (9.99-27.84)
Ciprofloxacin(5) 37 (38.61-61.39) 21 (18.11-38.65) 58 (78.37) 16 (18.11-38.65)
Cotrimoxazole(25) 10 (5.72-21.3) 4 (0.25-10.56) 14 (18.91) 60 (72.16-90)
Doxycycline(30) 48 (53.99-75.74) 19 (15.72-35.63) 67 (90.54) 7 (2.79-16.13)
Gentamicin(10) 47 (52.54-74.48) 17 (13.39-32.56) 64 (86.48) 10 (5.72-21.3)
Levofloxacin(5) 25 (23.01-44.56) 26 (24.26-46.01) 51 (68.91) 23 (20.54-41.63)
Nalidixic acid(30) 8 (3.74-17.88) 29 (28.07-50.31) 37 (50.0) 37 (38.61-61.39)
Nitrofurantoin(50) 36 (37.26-60.04) 17 (13.39-32.56) 53 (71.62) 21 (18.11-38.65)
Table 3: Relative proportions of susceptibility and resistance profiles from all uropathogens isolated from outpatients.